PRG-1801

· Tongji Hospital

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PRG-1801, covering 2024-07-11 to 2025-11-28. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of PRG-1801 in Recurrent/Refractory Primary Immune Thrombocytopenia (ITP) [EARLY_Phase 1]